How to Buy Kiromic Biopharma Stock

Kiromic Biopharma Inc

Kiromic BioPharma, Inc. , an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors.

Kiromic Biopharma stock last closed at $4.39, up 3.78% from the previous day, and has decreased 82.15% in one year. It has underperformed other stocks in the Biotechnology industry by 0.59 percentage points. Kiromic Biopharma stock is currently +18.33% from its 52-week low of $3.71, and -83.79% from its 52-week high of $27.09.

There are currently 608,218 KRBP shares outstanding. The market capitalization of KRBP is $2.67M. In the last 24 hours, 290,556 KRBP shares were traded.

How to Buy Kiromic Biopharma Stock

Wondering how to invest in Kiromic Biopharma stock? Here's how.
  1. Choose where to buy Kiromic Biopharma stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you figure out where to buy Kiromic Biopharma stock.
  2. Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Pick your method of payment and add your info.
  4. Evaluate Kiromic Biopharma stock: The Kiromic Biopharma ticker symbol is KRBP. Is Kiromic Biopharma stock a good investment? Should you buy shares of KRBP? How do KRBP's underlying business fundamentals look? Do top analysts think Kiromic Biopharma is a good buy? Why has KRBP's stock price moved recently? (Hint: Our stock market analysis website can help you decide if KRBP is a good stock to buy).
  5. Execute your KRBP purchase: Decide if you will purchase KRBP shares at the current market price or use a limit order to purchase KRBP shares at a specific price.
  6. Get updates on your KRBP position: Create a watchlist to the latest updates on your position in Kiromic Biopharma stock.

Step 1: Choose where to buy Kiromic Biopharma stock

You will need a brokerage account in order to access the NASDAQ market and buy KRBP stock.

A brokerage account is an investment account that allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by opening an account with eToro now.

Open eToro Account

Step 2: Create a brokerage account

Now that you've picked your brokerage, you need to fill out some personal information so you are able to buy KRBP stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
  2. Input your personal info to open your new trading account.
  1. Send your details by pressing the "Create Account" button.
Get started with eToro today

Step 3: Fund your brokerage account

Now that you've created your account on the best app for stock investing, your next step is to transfer the money for your investment:

Watch the walkthrough below for more details depositing money into your new brokerage account.

Get started with eToro today

Step 4: Evaluate Kiromic Biopharma stock

Once you have chosen the best place to buy Kiromic Biopharma stock, it's important to research their stock before you invest, so you truly comprehend the risk and upside.

Kiromic Biopharma Numbers

KRBP Price
1w %
1y %
5y %
Fore. Rev. Growth
Fore. Earn. Growth
Market Cap
Next Earnings
Apr 6, 2023
Next Dividend

Kiromic Biopharma Fundamentals

WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on KRBP's stock page.

Is KRBP stock overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge KRBP's fair value.

Using relative valuations metrics:

  • KRBP may be overvalued based on its P/B ratio of 9.4x, relative to Biotechnology industry P/B ratio of 4.75x

You can do additional valuation analysis on KRBP's stock here.

A look at KRBP Cashflows and Balance Sheet


  • There are more short-term assets than long-term liabilities on the KRBP balance sheet.


  • KRBP has cash burn of 34729200. It does not have sufficient cash and short-term investments to cover this.
  • KRBP has a relatively high debt to equity ratio of 44.83.
  • KRBP has $432.70k in cash and short term investments. This is not sufficient to cover its annual cash burn of $34.73M.
  • There are more short-term liabilities than short-term assets on the KRBP balance sheet.

You can dig deeper into what analysts are projecting on the Kiromic Biopharma stock forecast page.

KRBP Technicals

MACD Signal
MACD Histogram
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D

Are KRBP executives and large shareholders buying or selling the stock?

Over the last 12 months, executives and large shareholders at KRBP have not bought or sold any shares.

Research more about who owns KRBP stock here.

Does KRBP provide a stable income stream?

No, Kiromic Biopharma doesn't provide an income stream by paying out dividends.

What others are saying about KRBP

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your KRBP purchase

There are two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a given dollar amount limit, use a limit order.

Hit the Open button and your broker will place your order.

If you require additional help buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Get updates on your KRBP position

Now that you own some KRBP shares, you'll want to keep up with your investment.

Make a watchlist to keep track of your KRBP stock.


How to Buy Stock in Kiromic Biopharma

To summarize, here are the 6 steps for buying Kiromic Biopharma stock:

  1. Choose where to buy Kiromic Biopharma stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Evaluate Kiromic Biopharma stock
  5. Execute your KRBP purchase
  6. Get updates on your KRBP position

If you require a brokerage account, eToro is our recommended venue.

Get Started with eToro Today

If you want to keep an eye on your new investment in Kiromic Biopharma, click below.

$4.39+0.16 (+3.78%)
Updated Mar 17, 2023
Open eToro Account
$4.39+0.16 (+3.78%)
Updated Mar 17, 2023
Open eToro Account


How much does it cost to buy one Kiromic Biopharma share?

As of Mar 17, 2023, it costs $4.39 to buy one share of Kiromic Biopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.456 shares of KRBP.

Get Started with eToro Today

What is the best way to buy Kiromic Biopharma stock?

One way to place an order for Kiromic Biopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.